Faraday Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on preventing heart failure by reducing myocardial damage in acute ST-elevation myocardial infarction (STEMI) through ...

ST-elevated myocardial infarction more accurately than a clinician in an emergency department, which might upend standard ...

A study has found that moderate-to-severe obstructive sleep apnea increases risk for incident myocardial infarction between 12 and 5:59 AM.

A study in rats found that ingesting chitosan, a dietary fiber from shells, significantly increased the fecal excretion rate ...

A new study reveals that heart attack survivors could greatly reduce their risk of a second event by starting combination ...

Not everyone is sold on the benefits of early ezetimibe use, especially given the modest effect seen in IMPROVE-IT.

This platform can help identify early symptoms of diseases like atherosclerosis, venous thrombosis, cardiovascular diseases, ...

Ten years after learning their polygenic risk score, patients had fewer events—perhaps due to greater use of statin therapy.

Incidental physical activity is linked to a reduced risk for cardiovascular outcomes and may substantially benefit ...

Researchers have identified in a new study published in BMJ Open Heart journal that ventricular arrhythmias during stress ...

The molecular mechanism behind why heart attacks can vary in severity depending on the time of day has been uncovered by ...

Jury awards family, condemning Orlando Health’s "reckless" delays and in-network prioritization in fatal heart attack case.